Skip to main content
. 2021 Jun 10;6:670006. doi: 10.3389/frma.2021.670006

TABLE 4.

Comparison of Source Coverage and Overlap of Unique Drug and Drug Labeling Sections.

Coverage (%) Overlap (%)
Drug labeling section Drugs@FDA  DailyMed DrugBank Drugs@FDA  DailyMed DrugBank
Boxed warning 83.01 77.79 36.62 39.08
Indication 56.97 75.01 96.49 89.07 80.75 66.04
Dosage and admin 67.85 88.97 41.87 31.93
Use in specific populations
 Pregnancy 74.44 85.07 39.97 34.97
 Lactation 94.56 68.52 33.35 46.03
Clinical pharmacology
 Mechanism of action 56.23 51.64 96.93 86.67 91.46 53.47
 Pharmacodynamics 43.38 38.04 95.51 84.36 91.10 38.97
Pharmacokinetics
 Absorption 41.48 34.33 96.68 82.69 91.26 36.63
 Food effect 92.35 63.14 30.04 43.94
 Distribution 53.05 44.09 88.28 76.87 85.33 44.28
 Metabolism 47.92 38.73 96.07 81.26 90.97 42.26
 Excretion 49.43 41.36 93.97 81.10 89.30 43.29
Drug 90.12 71.00 91.28 82.00 95.96 82.89

The coverage represents the percentages are relative to total counts of 3,624 unique drug, 977 unique boxed warning section, 3,414 unique indication section, 2,883 unique dosage and administration section, 2,578 unique pregnancy section, 1,655 unique lactation section, 3,356 of mechanism of action section, 3,294 pharmacodynamics section, and 3,134 absorption section, 510 food effect section, 2,722 distribution section, 3,101 metabolism section, 3,051 excretion section parsed from pharmacokinetics section. The overlap represents the percentages of the average number of sources sharing each labeling section.